{
  "directed": true,
  "graph": {
    "annotation_curie": [],
    "annotation_list": {},
    "annotation_miriam": [],
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright Â© 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "The O-GlcNAc modification protects against protein misfolding and aggregation in neurodegenerative disease",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hp-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/rgd-names.belns"
    },
    "path": "tau/ryan2019.bel",
    "pybel_version": "0.15.3"
  },
  "links": [
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The addition and removal of OGlcNAc onto protein substrates is governed entirely by two ubiquitously expressed enzymes: O-GlcNAc transferase [EC 2.4.1.255] (OGT) and O-GlcNAc hydrolase [EC 3.2.1.169] (OGA) respectively (see Figure 2).",
      "key": "5e6525114afe6b4554020607dcf5ca05",
      "line": 82,
      "relation": "increases",
      "source": 67,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "OGT-mediated transfer of O-GlcNAc onto proteins is therefore closely tied to cellular glucose concentrations, though notably glucosamine and GlcNAc may also be recycled via salvage pathways",
      "key": "e0314e882ae2922e29e52867cc8f7705",
      "line": 90,
      "relation": "increases",
      "source": 67,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, downregulation of OGT leads to increased tau phosphorylation and onset of AD pathology.",
      "key": "467369e160b2b1400e41ed6567207c48",
      "line": 425,
      "relation": "decreases",
      "source": 67,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 61
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G was able to decrease effectively aggregation in tau-BiFC cells, even after treatment with BZX2, an OGT inhibitor reported to downregulate O-GlcNAcylation and promote phosphorylation and aggregation",
      "key": "3b5f1f95ef46e7d8289007f3246567c2",
      "line": 509,
      "relation": "decreases",
      "source": 67,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 61
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, downregulation of OGT leads to increased tau phosphorylation and onset of AD pathology.",
      "key": "d12d09ac21f8e96f5ba9ab5851373578",
      "line": 426,
      "relation": "negativeCorrelation",
      "source": 67,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 108
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G was able to decrease effectively aggregation in tau-BiFC cells, even after treatment with BZX2, an OGT inhibitor reported to downregulate O-GlcNAcylation and promote phosphorylation and aggregation",
      "key": "045201f7efa3e751f3ef3fa27b385771",
      "line": 508,
      "relation": "increases",
      "source": 67,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 58
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G was able to decrease effectively aggregation in tau-BiFC cells, even after treatment with BZX2, an OGT inhibitor reported to downregulate O-GlcNAcylation and promote phosphorylation and aggregation",
      "key": "b5e8021233e2af37da505219be1f373c",
      "line": 510,
      "relation": "decreases",
      "source": 67,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 7
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "OGT-mediated transfer of O-GlcNAc onto proteins is therefore closely tied to cellular glucose concentrations, though notably glucosamine and GlcNAc may also be recycled via salvage pathways",
      "key": "7d0feda1a31418543d4b5756d1f52966",
      "line": 91,
      "relation": "association",
      "source": 86,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In fact, it has been found that a decreased availability of glucose invokes a considerable reduction in the level of O-GlcNAc present in the mouse brain",
      "key": "ef1ddf6fd892cb39ab65a8dcba018e0b",
      "line": 101,
      "relation": "positiveCorrelation",
      "source": 86,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, increased levels of O-GlcNAc via pharmacological OGA inhibition have frequently led to alterations in protein phosphorylation levels",
      "key": "3d31f64b3a1e40f797c12b3d8f067fa6",
      "line": 143,
      "relation": "negativeCorrelation",
      "source": 86,
      "target": 66,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, increased levels of O-GlcNAc via pharmacological OGA inhibition have frequently led to alterations in protein phosphorylation levels",
      "key": "c6e4de22b4f7e9d351791f1510683a6d",
      "line": 144,
      "relation": "association",
      "source": 86,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "A proteomics study conducted by Hart and co-workers found that globally elevated OGlcNAcylation levels lowered phosphorylation at 280 sites while actually increasing it at 148 other sites",
      "key": "e1134e3ef478b46e7fc8ff96087f1133",
      "line": 152,
      "relation": "association",
      "source": 86,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Gong and co-workers identified that impaired brain glucose metabolism actually leads to neurofibrillary degeneration via downregulation of O-GlcNAcylation.",
      "key": "c988e9c1bd95ff7b8a48db38a5c94e76",
      "line": 446,
      "relation": "association",
      "source": 86,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Gong and co-workers identified that impaired brain glucose metabolism actually leads to neurofibrillary degeneration via downregulation of O-GlcNAcylation.",
      "key": "79d392e1685bce161e4e910b998eeb6d",
      "line": 447,
      "relation": "negativeCorrelation",
      "source": 86,
      "target": 14,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "key": "58737357abd720a0f2b517c7e646d87a",
      "relation": "hasVariant",
      "source": 85,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The addition and removal of OGlcNAc onto protein substrates is governed entirely by two ubiquitously expressed enzymes: O-GlcNAc transferase [EC 2.4.1.255] (OGT) and O-GlcNAc hydrolase [EC 3.2.1.169] (OGA) respectively (see Figure 2).",
      "key": "1ad0fd0283b16a5933090001e76b26b2",
      "line": 83,
      "relation": "increases",
      "source": 66,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, increased levels of O-GlcNAc via pharmacological OGA inhibition have frequently led to alterations in protein phosphorylation levels",
      "key": "262a3c85f42bb3f8980de676b5c9d6e7",
      "line": 143,
      "relation": "negativeCorrelation",
      "source": 66,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 86
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Knockout studies in mice suggest OGA plays a critical role in brain development",
      "key": "9c84809ad621c4d8dcd3843b60eb30cc",
      "line": 116,
      "relation": "association",
      "source": 66,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "b471b904672648c18447b7872c304714",
      "line": 340,
      "relation": "decreases",
      "source": 66,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 65
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "71373853a89745684b3b5c3814d553be",
      "line": 344,
      "relation": "decreases",
      "source": 66,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 49
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "Neuro-2a cell",
            "namespace": "CellLine"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Meanwhile, Vocadlo and co-workers reported that pharmacological inhibition of OGA, in each of neuroblastoma N2a cells, primary rat neurons, and a mouse brain, actually stimulates autophagy via an mTOR independent pathway",
      "key": "958ba0945f9c814cadb2592c3ad45995",
      "line": 372,
      "relation": "decreases",
      "source": 66,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 34
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Inactivation of OGA dramatically promoted HD model toxicity while removal of OGT worked to alleviate toxicity",
      "key": "57b8128a10fd17aa06861ce90ab73fec",
      "line": 685,
      "relation": "decreases",
      "source": 66,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 56
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "OGT-mediated transfer of O-GlcNAc onto proteins is therefore closely tied to cellular glucose concentrations, though notably glucosamine and GlcNAc may also be recycled via salvage pathways",
      "key": "dac7f7d758df80820e4e2884b2a728c0",
      "line": 91,
      "relation": "association",
      "source": 26,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In fact, it has been found that a decreased availability of glucose invokes a considerable reduction in the level of O-GlcNAc present in the mouse brain",
      "key": "71b398dd231ade78c9939277b188f174",
      "line": 101,
      "relation": "positiveCorrelation",
      "source": 3,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, hyperglycaemic conditions yield increased levels of O-GlcNAc",
      "key": "4686986a574cdcd772870f0e8f71b1c1",
      "line": 109,
      "relation": "increases",
      "source": 114,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Knockout studies in mice suggest OGA plays a critical role in brain development",
      "key": "0470b9176621f7f83eeef3982dc4d2a7",
      "line": 116,
      "relation": "association",
      "source": 25,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Though highly potent, PUGNAc (1, Scheme 1) was found to also effectively inhibit human lysosomal hexosaminidase, limiting its utility",
      "key": "6d2fd15e96b96f73863163b622f8e8ae",
      "line": 125,
      "relation": "decreases",
      "source": 21,
      "target": 66,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "SH-SY5Y",
            "namespace": "CellLine"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of SH-SY5Y neuroblastoma with PUGNAc, an OGA inhibitor, has increased levels of O-GlcNAc modified APP and secretion of sAPPÎ± while decreasing secretion of AÎ²40",
      "key": "b61c9a4313d3f69a9b1e9c273474b025",
      "line": 587,
      "relation": "decreases",
      "source": 21,
      "target": 66,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Lysosomes",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Though highly potent, PUGNAc (1, Scheme 1) was found to also effectively inhibit human lysosomal hexosaminidase, limiting its utility",
      "key": "aa957206d54b9e50e9a8a427bac773d4",
      "line": 127,
      "relation": "decreases",
      "source": 21,
      "target": 19,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "SH-SY5Y",
            "namespace": "CellLine"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of SH-SY5Y neuroblastoma with PUGNAc, an OGA inhibitor, has increased levels of O-GlcNAc modified APP and secretion of sAPPÎ± while decreasing secretion of AÎ²40",
      "key": "a5b796890624c199ae7ca96ec2a45118",
      "line": 588,
      "relation": "increases",
      "source": 21,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent work indicated that O-GlcNAcylation of APP promotes its plasma membrane localization, facilitating its non-amyloidogenic processing",
      "key": "cdddeb50fc2e1d8992a7bca818b48a9d",
      "line": 625,
      "relation": "increases",
      "source": 21,
      "target": 52
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "SH-SY5Y",
            "namespace": "CellLine"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of SH-SY5Y neuroblastoma with PUGNAc, an OGA inhibitor, has increased levels of O-GlcNAc modified APP and secretion of sAPPÎ± while decreasing secretion of AÎ²40",
      "key": "a074bff53a9602c83234f97a4d1e38ba",
      "line": 589,
      "relation": "increases",
      "source": 21,
      "target": 47,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "identifier": "0005622",
            "name": "intracellular",
            "namespace": "go"
          },
          "toLoc": {
            "identifier": "0005615",
            "name": "extracellular space",
            "namespace": "go"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "SH-SY5Y",
            "namespace": "CellLine"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of SH-SY5Y neuroblastoma with PUGNAc, an OGA inhibitor, has increased levels of O-GlcNAc modified APP and secretion of sAPPÎ± while decreasing secretion of AÎ²40",
      "key": "5f6f7e3d2757e43f0213afd2037c1c48",
      "line": 590,
      "relation": "decreases",
      "source": 21,
      "target": 0,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "identifier": "0005622",
            "name": "intracellular",
            "namespace": "go"
          },
          "toLoc": {
            "identifier": "0005615",
            "name": "extracellular space",
            "namespace": "go"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "PUGNAc treatment increased the rate of APP trafficking to the plasma membrane from the trans- Golgi network and decreased the rate of APP endocytosis",
      "key": "b6f209078bc8175d982ab0df4d097046",
      "line": 617,
      "relation": "increases",
      "source": 21,
      "target": 50,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "name": "trans-Golgi network",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "plasma membrane",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "PUGNAc treatment increased the rate of APP trafficking to the plasma membrane from the trans- Golgi network and decreased the rate of APP endocytosis",
      "key": "74663c4353fccf4cfda83e005d679d49",
      "line": 618,
      "relation": "decreases",
      "source": 21,
      "target": 50,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent work indicated that O-GlcNAcylation of APP promotes its plasma membrane localization, facilitating its non-amyloidogenic processing",
      "key": "1f96fd029b0fc215b8f895e83191cafa",
      "line": 628,
      "relation": "increases",
      "source": 21,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G is able to permeate the blood-brain barrier and is highly selective for human OGA",
      "key": "6de12ed363d23a8b0e24052caee416e0",
      "line": 135,
      "relation": "increases",
      "source": 20,
      "target": 20,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "name": "Blood",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Brain",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G is able to permeate the blood-brain barrier and is highly selective for human OGA",
      "key": "99fc2aff70f42addff04cc2f01c731e5",
      "line": 136,
      "relation": "decreases",
      "source": 20,
      "target": 66,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "988a6216d75fcea064f4db497e95296f",
      "line": 339,
      "relation": "decreases",
      "source": 20,
      "target": 66,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "8cdae2a2d51f1df9bd41d2c343e5e9cf",
      "line": 341,
      "relation": "increases",
      "source": 20,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "51ab6a3ad1d1a3ead31ff5f424d5bc99",
      "line": 342,
      "relation": "increases",
      "source": 20,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment increased levels of monomeric ASyn after 7 days by 50% relative to the control.",
      "key": "be0989deb761882cc261657a57e8cb2d",
      "line": 353,
      "relation": "increases",
      "source": 20,
      "target": 68
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "PC-12 cell",
            "namespace": "CellLine"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Acute treatment with Thiamet-G effectively decreased phosphorylation of tau at pathologically relevant sites, Thr231 and Ser396, in PC-12 cells",
      "key": "c070c3ace6dd9f8310668955b5ff90b0",
      "line": 495,
      "relation": "decreases",
      "source": 20,
      "target": 63
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "PC-12 cell",
            "namespace": "CellLine"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Acute treatment with Thiamet-G effectively decreased phosphorylation of tau at pathologically relevant sites, Thr231 and Ser396, in PC-12 cells",
      "key": "64a6d4dc7e2bbc791dc2f17757ac504e",
      "line": 496,
      "relation": "decreases",
      "source": 20,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G was able to decrease effectively aggregation in tau-BiFC cells, even after treatment with BZX2, an OGT inhibitor reported to downregulate O-GlcNAcylation and promote phosphorylation and aggregation",
      "key": "dda4927ccf12e3403b570133ba1e8ee9",
      "line": 507,
      "relation": "decreases",
      "source": 20,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Long-term treatment of JNPL3 tau tg mice with Thiamet- G increased levels of O-GlcNAc modified tau while decreasing levels of tau aggregates and neuron death",
      "key": "a8d4bc62505c3a920cc178f5cbdbde74",
      "line": 534,
      "relation": "decreases",
      "source": 20,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "1e7a64ba06e51cc37d132a285d05666e",
      "line": 554,
      "relation": "decreases",
      "source": 20,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent studies on rTg4510 mice found their chronic treatment reduced pathological tau in the brain besides total tau in the CSF also.",
      "key": "6bff84bb96a56fb25a19d5be110aa152",
      "line": 565,
      "relation": "decreases",
      "source": 20,
      "target": 7,
      "target_modifier": {
        "location": {
          "name": "Brain",
          "namespace": "MESH"
        }
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Cerebral Cortex",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Hippocampus",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G remains effective in vivo, efficiently reducing phosphorylation at Thr231, Ser396 and Ser422 in both rat cortex and hippocampus.",
      "key": "2ab4451409363824ea856288c5b32b8c",
      "line": 520,
      "relation": "decreases",
      "source": 20,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Cerebral Cortex",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Hippocampus",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G remains effective in vivo, efficiently reducing phosphorylation at Thr231, Ser396 and Ser422 in both rat cortex and hippocampus.",
      "key": "4f10b347e4359f5fd0c13f907951e38e",
      "line": 521,
      "relation": "decreases",
      "source": 20,
      "target": 103
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Cerebral Cortex",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Hippocampus",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G remains effective in vivo, efficiently reducing phosphorylation at Thr231, Ser396 and Ser422 in both rat cortex and hippocampus.",
      "key": "e5da40a4b44cb6b63a69c75d22851c8a",
      "line": 522,
      "relation": "decreases",
      "source": 20,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Long-term treatment of JNPL3 tau tg mice with Thiamet- G increased levels of O-GlcNAc modified tau while decreasing levels of tau aggregates and neuron death",
      "key": "cdd2449f82b4ff9a67cbd45d51fb8bfd",
      "line": 533,
      "relation": "increases",
      "source": 20,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "c401f11ed0aca1b77b45c784c7b0162b",
      "line": 548,
      "relation": "increases",
      "source": 20,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Long-term treatment of JNPL3 tau tg mice with Thiamet- G increased levels of O-GlcNAc modified tau while decreasing levels of tau aggregates and neuron death",
      "key": "d3904904c1a4caa3bad87bd38533156a",
      "line": 535,
      "relation": "decreases",
      "source": 20,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "8d36c11b96d1733e1e7d81494f3ecc7e",
      "line": 549,
      "relation": "decreases",
      "source": 20,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "ab894caead137500d4da0a2ec9da8272",
      "line": 550,
      "relation": "decreases",
      "source": 20,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "2cd4661840967362b8d3c46c4d591d4d",
      "line": 551,
      "relation": "decreases",
      "source": 20,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "b51aa9116467579dacd710bdd2e3c79b",
      "line": 552,
      "relation": "decreases",
      "source": 20,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "2e6b5fcef8f8f9e3aaed6874839ba921",
      "line": 553,
      "relation": "causesNoChange",
      "source": 20,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent studies on rTg4510 mice found their chronic treatment reduced pathological tau in the brain besides total tau in the CSF also.",
      "key": "e1d0c1f70dd6a66fb8bfdff3771617e8",
      "line": 566,
      "relation": "decreases",
      "source": 20,
      "target": 57,
      "target_modifier": {
        "location": {
          "name": "Cerebrospinal Fluid",
          "namespace": "MESH"
        }
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "c0ad2a93fa9269a78987bff10304b46a",
      "line": 637,
      "relation": "increases",
      "source": 20,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "5abfab1b65c92bebabaae4d9a8430d1a",
      "line": 638,
      "relation": "decreases",
      "source": 20,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "560dc9b54b5601f5d739a55086046739",
      "line": 639,
      "relation": "decreases",
      "source": 20,
      "target": 112
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "33a5a02651d6e6aa88e4cbd487f0e3b9",
      "line": 641,
      "relation": "causesNoChange",
      "source": 20,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, increased levels of O-GlcNAc via pharmacological OGA inhibition have frequently led to alterations in protein phosphorylation levels",
      "key": "3064a5f5ff9f9f6d596b3636fa3fcbf3",
      "line": 144,
      "relation": "association",
      "source": 32,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "A proteomics study conducted by Hart and co-workers found that globally elevated OGlcNAcylation levels lowered phosphorylation at 280 sites while actually increasing it at 148 other sites",
      "key": "2076410b9e7dc2668a2c4463424fdce6",
      "line": 152,
      "relation": "association",
      "source": 32,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Substantia Nigra",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "PD is characterised by the progressive degeneration of dopamine-producing neurons in the substantia nigra, resulting in impaired motor function",
      "key": "ee6483292352e7c92bce01e2b4b02f10",
      "line": 161,
      "relation": "positiveCorrelation",
      "source": 111,
      "target": 6,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The current consensus is that ASyn self-assembly plays a critical role in PD, whether it be a cause or symptom of the complex pathological cascade.",
      "key": "19366e48a67316a275ef5feb0bd4e655",
      "line": 186,
      "relation": "association",
      "source": 111,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Calpain activity correlates with disease progression in PD mouse models",
      "key": "73f9b7d622f3cb8bef8a194ceec0c2fb",
      "line": 243,
      "relation": "association",
      "source": 111,
      "target": 84,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "As mentioned previously, calpain activity correlates well with disease progression in PD mouse models, catalysing the truncation of ASyn into aggregation-prone species",
      "key": "6905bc195281cacb4d35c2018c5ddb0e",
      "line": 309,
      "relation": "association",
      "source": 111,
      "target": 84,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Substantia Nigra",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "PD is characterised by the progressive degeneration of dopamine-producing neurons in the substantia nigra, resulting in impaired motor function",
      "key": "f6d63fe2c5bbfb20082dc0aabf40c3fd",
      "line": 161,
      "relation": "positiveCorrelation",
      "source": 6,
      "source_modifier": {
        "modifier": "Degradation"
      },
      "target": 111
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Substantia Nigra",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "PD is characterised by the progressive degeneration of dopamine-producing neurons in the substantia nigra, resulting in impaired motor function",
      "key": "e030a3ad5f19f1a14e21f8b304c17b79",
      "line": 162,
      "relation": "negativeCorrelation",
      "source": 6,
      "source_modifier": {
        "modifier": "Degradation"
      },
      "target": 29
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Substantia Nigra",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "PD is characterised by the progressive degeneration of dopamine-producing neurons in the substantia nigra, resulting in impaired motor function",
      "key": "7d9f9c697ec16cad1964136c6618519e",
      "line": 162,
      "relation": "negativeCorrelation",
      "source": 29,
      "target": 6,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "This impairment manifests compromised postural reflexes, muscular rigidity and bradykinesia in patients.",
      "key": "cc83362ede34c566b4494b6b79a932fa",
      "line": 170,
      "relation": "decreases",
      "source": 29,
      "target": 115
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "This impairment manifests compromised postural reflexes, muscular rigidity and bradykinesia in patients.",
      "key": "dd155c32f028776c3fbd41eabd8e770f",
      "line": 171,
      "relation": "decreases",
      "source": 29,
      "target": 110
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "This impairment manifests compromised postural reflexes, muscular rigidity and bradykinesia in patients.",
      "key": "944be47deae4f6e2f89f328d22de1d4d",
      "line": 172,
      "relation": "decreases",
      "source": 29,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Point mutations in the ASyn gene (SNCA) underlie familial disorders with parkinsonian characteristics, suggesting a pathogenic role for ASyn accumulation",
      "key": "ce2200a64d7b17001b039c0c7a6f9267",
      "line": 179,
      "relation": "increases",
      "source": 80,
      "target": 111
    },
    {
      "key": "f330221a26c90e449c53889c40f0191c",
      "relation": "hasVariant",
      "source": 68,
      "target": 80
    },
    {
      "key": "c6121f5280d6c5a591acb147a6a7393b",
      "relation": "partOf",
      "source": 68,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Reports suggest ASyn has a role in regulating supply and management of synaptic vesicles,[57] while also possibly regulating neuronal release of dopamine, a neurotransmitter involved in controlling voluntary and involuntary movement",
      "key": "b4e9d2589a39eb14c8db2f1fc7de7e4b",
      "line": 195,
      "relation": "regulates",
      "source": 68,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Neurons",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Reports suggest ASyn has a role in regulating supply and management of synaptic vesicles,[57] while also possibly regulating neuronal release of dopamine, a neurotransmitter involved in controlling voluntary and involuntary movement",
      "key": "28d3fa7bbad9af46d1499642b5c62fd2",
      "line": 197,
      "relation": "association",
      "source": 68,
      "target": 27
    },
    {
      "key": "6caabf974798ac57a30704e2a7902caa",
      "relation": "partOf",
      "source": 68,
      "target": 36
    },
    {
      "key": "54c6a8ab9cbc96aeb692a6d5c2bee4d6",
      "relation": "partOf",
      "source": 68,
      "target": 40
    },
    {
      "key": "3a489e762684bc46f93e2d7df1019b34",
      "relation": "hasVariant",
      "source": 68,
      "target": 72
    },
    {
      "key": "0504ec2d5192b0c293191a15515a9a46",
      "relation": "hasVariant",
      "source": 68,
      "target": 71
    },
    {
      "key": "589a2860158013bd5381b539cfe9186f",
      "relation": "hasVariant",
      "source": 68,
      "target": 79
    },
    {
      "key": "b5bf91095df45d6f9ab416aec869d9d1",
      "relation": "hasVariant",
      "source": 68,
      "target": 73
    },
    {
      "key": "8a4d36f326ebe1a69dfcab9ad54fe6e1",
      "relation": "hasVariant",
      "source": 68,
      "target": 76
    },
    {
      "key": "33cf8314c13dd8f2dcf1869f1669ece3",
      "relation": "hasVariant",
      "source": 68,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "TEM found semisynthetic ASyngS87 forms shorter fibrils than the wildtype, while ASyngT72 formed only small, broken fibrils",
      "key": "58e07c7ef9ebf2237b7040d258b1d9fa",
      "line": 283,
      "relation": "increases",
      "source": 68,
      "target": 11
    },
    {
      "key": "19e162a2ff1e37d0862e636be7de5e68",
      "relation": "hasVariant",
      "source": 68,
      "target": 77
    },
    {
      "key": "941efa0581132bd739931808e05bbd44",
      "relation": "hasVariant",
      "source": 68,
      "target": 78
    },
    {
      "key": "61e065efd163e7913cdd6ea923407ce8",
      "relation": "hasVariant",
      "source": 68,
      "target": 75
    },
    {
      "key": "f1ec33113c2c3428850f1a9335670b48",
      "relation": "hasVariant",
      "source": 68,
      "target": 69
    },
    {
      "key": "5201837d5ee5cafde8184f9421ee8641",
      "relation": "hasVariant",
      "source": 68,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The current consensus is that ASyn self-assembly plays a critical role in PD, whether it be a cause or symptom of the complex pathological cascade.",
      "key": "ae725ac4b31ed6d7d57caf5638aed5e9",
      "line": 186,
      "relation": "association",
      "source": 39,
      "target": 111
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Neurons",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Reports suggest ASyn has a role in regulating supply and management of synaptic vesicles,[57] while also possibly regulating neuronal release of dopamine, a neurotransmitter involved in controlling voluntary and involuntary movement",
      "key": "b3ea49506ce59330989419458d7b4f51",
      "line": 197,
      "relation": "association",
      "source": 27,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Neurons",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Reports suggest ASyn has a role in regulating supply and management of synaptic vesicles,[57] while also possibly regulating neuronal release of dopamine, a neurotransmitter involved in controlling voluntary and involuntary movement",
      "key": "9c91119c653a0170ec9111f5e1b3db74",
      "line": 198,
      "relation": "association",
      "source": 27,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Neurons",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Reports suggest ASyn has a role in regulating supply and management of synaptic vesicles,[57] while also possibly regulating neuronal release of dopamine, a neurotransmitter involved in controlling voluntary and involuntary movement",
      "key": "7585d187d71fa1bf10b69588ee8b5944",
      "line": 198,
      "relation": "association",
      "source": 30,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Cell Membrane",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "ASyn binds simultaneously to plasma membrane phospholipids (via its N-terminal domain) and to synaptobrevin-2 (via its C-terminal domain) to promote SNARE-complex assembly.",
      "key": "0b394ac78d684b0868b69db81e57446b",
      "line": 206,
      "relation": "increases",
      "source": 36,
      "target": 23
    },
    {
      "key": "d70b09faa7826e6fb46e901d5f862cc2",
      "relation": "partOf",
      "source": 4,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "ASyn binds simultaneously to plasma membrane phospholipids (via its N-terminal domain) and to synaptobrevin-2 (via its C-terminal domain) to promote SNARE-complex assembly.",
      "key": "f65c4a27d5d620c67895321cd426472d",
      "line": 208,
      "relation": "increases",
      "source": 40,
      "target": 23
    },
    {
      "key": "23b9d2a3bfa7cf68174198b30b4e6ccd",
      "relation": "partOf",
      "source": 83,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "It has been suggested that large ASyn aggregates actually work to sequester other harmful conformers, thus acting in a neuroprotective manner.",
      "key": "29e70d1056e3a8d9312ae14c9441d338",
      "line": 214,
      "relation": "decreases",
      "source": 10,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The authors suggested that OGlcNAcylation as studied in their case, had promoted oligomer-formation underlying the reduced aggregation",
      "key": "42ca959c987144b85636d01e61d7f0c2",
      "line": 331,
      "relation": "negativeCorrelation",
      "source": 10,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Notably, cleavages at the ASyn C-terminus typically increase the resultant truncated proteinâs aggregation, as has been demonstrated in vitro and in overexpression experiments",
      "key": "b8fe3b6fd0955c8d94903e3f3422c41b",
      "line": 222,
      "relation": "increases",
      "source": 72,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Specifically calpain, a cysteine protease, cleaves soluble ASyn at a number of sites.",
      "key": "d1448022bb8e9fa80bbe2ef813254f0c",
      "line": 229,
      "relation": "increases",
      "source": 84,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "As mentioned previously, calpain activity correlates well with disease progression in PD mouse models, catalysing the truncation of ASyn into aggregation-prone species",
      "key": "38bab9f8eabd17afcc7afee20a84514c",
      "line": 310,
      "relation": "increases",
      "source": 84,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 71
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Calpain also cleaves ASyn fibres to generate C-truncated forms which promote seeded aggregation",
      "key": "b29f00c328d62233266107887a353bbe",
      "line": 235,
      "relation": "increases",
      "source": 84,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Calpain activity correlates with disease progression in PD mouse models",
      "key": "970d594290d659236bb30bce1475c6db",
      "line": 243,
      "relation": "association",
      "source": 84,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 111
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "As mentioned previously, calpain activity correlates well with disease progression in PD mouse models, catalysing the truncation of ASyn into aggregation-prone species",
      "key": "9a7c6490c50c6df2c20fd049400eb616",
      "line": 309,
      "relation": "association",
      "source": 84,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 111
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Both the synthetic ASyngT72 and ASyngS87 peptides exhibit strong resistances to cleavage from recombinant calpain, where unmodified ASyn is degraded rapidly",
      "key": "958674739f278655c6c932011f8e202a",
      "line": 320,
      "relation": "causesNoChange",
      "source": 84,
      "target": 76,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Both the synthetic ASyngT72 and ASyngS87 peptides exhibit strong resistances to cleavage from recombinant calpain, where unmodified ASyn is degraded rapidly",
      "key": "c1c45a60d1aac55f0c57e7b4a14d505e",
      "line": 321,
      "relation": "causesNoChange",
      "source": 84,
      "target": 74,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Both the synthetic ASyngT72 and ASyngS87 peptides exhibit strong resistances to cleavage from recombinant calpain, where unmodified ASyn is degraded rapidly",
      "key": "55cdf90c230b944e3ddbc27a81c37f4c",
      "line": 322,
      "relation": "increases",
      "source": 84,
      "target": 68,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "As mentioned previously, calpain activity correlates well with disease progression in PD mouse models, catalysing the truncation of ASyn into aggregation-prone species",
      "key": "a539b8e5d7b8af6c10ff8320923435ca",
      "line": 311,
      "relation": "increases",
      "source": 71,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Calpain also cleaves ASyn fibres to generate C-truncated forms which promote seeded aggregation",
      "key": "7e8fe09d35ffeb5171f4916f17986e9a",
      "line": 236,
      "relation": "increases",
      "source": 46,
      "target": 10
    },
    {
      "key": "ce0cd6b70c8973feb629c953447d3f3a",
      "relation": "hasVariant",
      "source": 45,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "An estimated 90% of the proteins constituting ASyn aggregates bear phosphate groups at Ser129, suggesting that ASyn phosphorylation, or at least elevated levels of phosphorylated ASyn, contributes to PD pathogenesis",
      "key": "f48477dd887dcdfe5a62ec6265e81d5a",
      "line": 253,
      "relation": "increases",
      "source": 79,
      "target": 111
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The O-GlcNAc modification has been shown to slow the aggregation rate of ASyn relative to the wild-type.",
      "key": "469905655e7e6610b95da77d42884f5e",
      "line": 260,
      "relation": "decreases",
      "source": 73,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The authors suggested that OGlcNAcylation as studied in their case, had promoted oligomer-formation underlying the reduced aggregation",
      "key": "8b4e8759f9d7b1d40251ae80754a391f",
      "line": 330,
      "relation": "increases",
      "source": 73,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Initially it was found that semisynthetic ASyn bearing an O-GlcNAc unit at Thr72 (ASyngT72) displayed a reduced self-assembling propensity relative to the wild-type during thioflavin T (ThT) fluorescence assay",
      "key": "2859594337b4edf354ae8131ca627783",
      "line": 269,
      "relation": "decreases",
      "source": 76,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In fact, ASyngT72 did not form aggregates even after 7 days of incubation",
      "key": "0a8fe22594f1888b05948dfd336678dd",
      "line": 275,
      "relation": "decreases",
      "source": 76,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "TEM found semisynthetic ASyngS87 forms shorter fibrils than the wildtype, while ASyngT72 formed only small, broken fibrils",
      "key": "89f80530827d589c40953fd3b8734784",
      "line": 282,
      "relation": "increases",
      "source": 76,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "TEM found semisynthetic ASyngS87 forms shorter fibrils than the wildtype, while ASyngT72 formed only small, broken fibrils",
      "key": "3f836f25a7ae1ced2fce2012f0a3348d",
      "line": 281,
      "relation": "increases",
      "source": 74,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "ASyngT75 and ASyngT81 formed rare, highly irregular aggregates, and the peptide tri-O-GlcNAcylated at all of Th72/Thr81/Ser87 did not aggregate at all.",
      "key": "2a8dc3ee1374780b7b8e7531a630ea4a",
      "line": 290,
      "relation": "increases",
      "source": 77,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "ASyngT75 and ASyngT81 formed rare, highly irregular aggregates, and the peptide tri-O-GlcNAcylated at all of Th72/Thr81/Ser87 did not aggregate at all.",
      "key": "e3324ed0ef9a244fac738f1442578b0e",
      "line": 291,
      "relation": "increases",
      "source": 78,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "ASyngT75 and ASyngT81 formed rare, highly irregular aggregates, and the peptide tri-O-GlcNAcylated at all of Th72/Thr81/Ser87 did not aggregate at all.",
      "key": "0b351f5e27dc6670642a87106a7b194a",
      "line": 292,
      "relation": "causesNoChange",
      "source": 75,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "An unmodified control, ASyn68-77, significantly accelerated wild-type aggregation while the GlcNAcylated analogue did not.",
      "key": "12b1747ff1bd14cda4b15a70b26b5303",
      "line": 299,
      "relation": "increases",
      "source": 69,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "An unmodified control, ASyn68-77, significantly accelerated wild-type aggregation while the GlcNAcylated analogue did not.",
      "key": "c511063b133fef640014b47a311bc649",
      "line": 300,
      "relation": "increases",
      "source": 70,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The authors suggested that OGlcNAcylation as studied in their case, had promoted oligomer-formation underlying the reduced aggregation",
      "key": "5ccd778e8e5e19cc324606b13cf912eb",
      "line": 331,
      "relation": "negativeCorrelation",
      "source": 12,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "b9ef35e8fb67d8b24d32ddab47686b3f",
      "line": 343,
      "relation": "decreases",
      "source": 65,
      "target": 34
    },
    {
      "key": "c0c6b9bd2f445b62dca0b1b0dae9facc",
      "relation": "hasVariant",
      "source": 64,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent re-activation of autophagy via rapamycin, an mTOR inhibitor, attenuated the increase in ASyn accumulation also.",
      "key": "3a641095fd9a5ac7d47df7c874b98033",
      "line": 361,
      "relation": "increases",
      "source": 64,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 68
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "01e69cf8379920fee40c2a1b6f9f3e1c",
      "line": 345,
      "relation": "decreases",
      "source": 49,
      "target": 34
    },
    {
      "key": "028a29a6af2d70c841d7491116164883",
      "relation": "hasVariant",
      "source": 48,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "bd930bf58b219ad2e78baa47e34989cb",
      "line": 346,
      "relation": "increases",
      "source": 34,
      "target": 68,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent re-activation of autophagy via rapamycin, an mTOR inhibitor, attenuated the increase in ASyn accumulation also.",
      "key": "5aebcfe2bfdd97800bc0d60a85a3251d",
      "line": 363,
      "relation": "decreases",
      "source": 34,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent re-activation of autophagy via rapamycin, an mTOR inhibitor, attenuated the increase in ASyn accumulation also.",
      "key": "8dcbd63c71ad4099c64459d0b2bce7d4",
      "line": 360,
      "relation": "decreases",
      "source": 5,
      "target": 64,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent re-activation of autophagy via rapamycin, an mTOR inhibitor, attenuated the increase in ASyn accumulation also.",
      "key": "9f848dcf6afecac15e80482d51a21fa9",
      "line": 362,
      "relation": "decreases",
      "source": 5,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Meanwhile, Vocadlo and co-workers reported that pharmacological inhibition of OGA, in each of neuroblastoma N2a cells, primary rat neurons, and a mouse brain, actually stimulates autophagy via an mTOR independent pathway",
      "key": "084691a1a319bfb207fe74690ac7584b",
      "line": 376,
      "relation": "decreases",
      "source": 96,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 34
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Meanwhile, Vocadlo and co-workers reported that pharmacological inhibition of OGA, in each of neuroblastoma N2a cells, primary rat neurons, and a mouse brain, actually stimulates autophagy via an mTOR independent pathway",
      "key": "a6d11d1fdd190eba34a230db15350899",
      "line": 381,
      "relation": "decreases",
      "source": 106,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 34
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Phosphorylation of tau regulates its modulatory functions by impairing its ability to bind microtubules.",
      "key": "5ae32ceee03ead342f5df35d829e59ed",
      "line": 390,
      "relation": "decreases",
      "source": 61,
      "target": 37
    },
    {
      "key": "080972dc80c9f38e1b7d1f7bc3b27b25",
      "relation": "hasVariant",
      "source": 57,
      "target": 61
    },
    {
      "key": "8b6b9bc97989061618adf5b808da8142",
      "relation": "partOf",
      "source": 57,
      "target": 37
    },
    {
      "key": "b5ef526ab5a17da51fd96bb875e02aac",
      "relation": "hasVariant",
      "source": 57,
      "target": 60
    },
    {
      "key": "46b6bc96f6baa314273d71c0957c0a9a",
      "relation": "hasVariant",
      "source": 57,
      "target": 58
    },
    {
      "key": "55599116f525633c7830f76570054ff3",
      "relation": "hasVariant",
      "source": 57,
      "target": 59
    },
    {
      "key": "91ce86daa5b2a97c12d586c86570973d",
      "relation": "hasVariant",
      "source": 57,
      "target": 63
    },
    {
      "key": "3ffb471e28c883ec4ff2ed3ff97b18e9",
      "relation": "hasVariant",
      "source": 57,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "64199631dad95eaa9c9e2c4545c80df0",
      "line": 402,
      "relation": "increases",
      "source": 37,
      "target": 57,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "key": "927477822675564e953e78c2bcccd4b9",
      "relation": "partOf",
      "source": 17,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "4735f448bbf4c07622e37a4d59893e44",
      "line": 401,
      "relation": "decreases",
      "source": 60,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "88a281722288cfedb49de03dee484515",
      "line": 403,
      "relation": "decreases",
      "source": 60,
      "target": 57,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "b562d4063ff4a51f43e2996653aee910",
      "line": 404,
      "relation": "increases",
      "source": 60,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "adae7a2831f5313efa27551b57c4a7d3",
      "line": 405,
      "relation": "increases",
      "source": 9,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Gong and co-workers identified that impaired brain glucose metabolism actually leads to neurofibrillary degeneration via downregulation of O-GlcNAcylation.",
      "key": "38dbbe3da64d20bce805620bc43f62f8",
      "line": 447,
      "relation": "negativeCorrelation",
      "source": 14,
      "source_modifier": {
        "modifier": "Degradation"
      },
      "target": 86
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "It was later found that tau phosphorylation was inversely regulated by OGlcNAc addition in vitro, in tissue culture cells, and ex vivo in rat brain slices (Figure 4)",
      "key": "a2a6f2a278cedc7247e210822766ec3e",
      "line": 417,
      "relation": "negativeCorrelation",
      "source": 101,
      "target": 102
    },
    {
      "key": "cd22a2875ff77f68d3759b708d225b91",
      "relation": "hasVariant",
      "source": 100,
      "target": 101
    },
    {
      "key": "82f0265529108a0f4bf777d240df7e0e",
      "relation": "hasVariant",
      "source": 100,
      "target": 102
    },
    {
      "key": "b6286fded6197691f26b7201d49bd5b1",
      "relation": "hasVariant",
      "source": 100,
      "target": 105
    },
    {
      "key": "8044154e4ba9593fe36ae88e096e65ac",
      "relation": "hasVariant",
      "source": 100,
      "target": 103
    },
    {
      "key": "617175eee665a6b4833c9e682151d551",
      "relation": "hasVariant",
      "source": 100,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "It was later found that tau phosphorylation was inversely regulated by OGlcNAc addition in vitro, in tissue culture cells, and ex vivo in rat brain slices (Figure 4)",
      "key": "038d07510f39f44f48d277da95c78482",
      "line": 417,
      "relation": "negativeCorrelation",
      "source": 102,
      "target": 101
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, downregulation of OGT leads to increased tau phosphorylation and onset of AD pathology.",
      "key": "54772f65b7e98d8ad56d46c75329d858",
      "line": 426,
      "relation": "negativeCorrelation",
      "source": 108,
      "target": 67,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Cerebral Cortex",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Finally, AD patient cortical brain tissues reportedly have significantly reduced levels of OGT expression compared to aged and post-mortem delay matched brain tissue.",
      "key": "f3c84fc473afbd5d4b1be46bb90a31a2",
      "line": 457,
      "relation": "decreases",
      "source": 108,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Low",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Hippocampus",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Twelve-month old triple-tg mice (3xTg-Ad) displayed reduced levels of tau O-GlcNAcylation consistent with tau hyperphosphorylation in the hippocampus.",
      "key": "d7e91e811d12b132446a981ba922f7c0",
      "line": 435,
      "relation": "negativeCorrelation",
      "source": 89,
      "target": 88
    },
    {
      "key": "d0260d683ca742c4ea3700a18197816c",
      "relation": "hasVariant",
      "source": 87,
      "target": 89
    },
    {
      "key": "9f9d22be0d4eaac98ab09cbe871b3a6b",
      "relation": "hasVariant",
      "source": 87,
      "target": 88
    },
    {
      "key": "d79a869941306702b91eaba37b9cad7a",
      "relation": "hasVariant",
      "source": 87,
      "target": 91
    },
    {
      "key": "244d61e1d0505db9d3a7a57a3bd33e51",
      "relation": "hasVariant",
      "source": 87,
      "target": 95
    },
    {
      "key": "8721751abe573e220a125852f580446f",
      "relation": "hasVariant",
      "source": 87,
      "target": 92
    },
    {
      "key": "abd3a5256d76c33862088b77c3589e2d",
      "relation": "hasVariant",
      "source": 87,
      "target": 93
    },
    {
      "key": "5bfbe01d7009c5533fbfe7ed53e707d4",
      "relation": "hasVariant",
      "source": 87,
      "target": 94
    },
    {
      "key": "94ab3b470caac00b6e5c020fd0c353f3",
      "relation": "hasVariant",
      "source": 87,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Low",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Hippocampus",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Twelve-month old triple-tg mice (3xTg-Ad) displayed reduced levels of tau O-GlcNAcylation consistent with tau hyperphosphorylation in the hippocampus.",
      "key": "dfa4c7acb7f1770a343cd70ec053ae55",
      "line": 435,
      "relation": "negativeCorrelation",
      "source": 88,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Gong and co-workers identified that impaired brain glucose metabolism actually leads to neurofibrillary degeneration via downregulation of O-GlcNAcylation.",
      "key": "a05d1bbf40705537b868f2e70f77d009",
      "line": 446,
      "relation": "association",
      "source": 28,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Beyond inhibiting its phosphorylation, the O-GlcNAc modification hinders tau oligomerization",
      "key": "e03e0262a86dccbb03de9fa4eb3880bc",
      "line": 464,
      "relation": "decreases",
      "source": 58,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Beyond inhibiting its phosphorylation, the O-GlcNAc modification hinders tau oligomerization",
      "key": "aac3729eae43f20d6fc13d45fc6147ff",
      "line": 465,
      "relation": "decreases",
      "source": 58,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Vocadlo and co-workers demonstrated that a recombinantly produced O-GlcNAc-modified tau construct (spanning residues 244- 441) formed oligomers at a slower rate, and to a lesser extent than the unmodified, recombinant control sequence during ThS fluorescence assays.",
      "key": "ecddfb90e9c6e1fdc77ccd74b27bc12d",
      "line": 473,
      "relation": "decreases",
      "source": 58,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Indeed, O-GlcNAc modification of tau-441 appeared to slow tauâs extension, perturbing the equilibrium position between oligomeric and free tau.",
      "key": "e100111adf873fcc6c279cbb31870f8f",
      "line": 481,
      "relation": "decreases",
      "source": 42,
      "target": 9
    },
    {
      "key": "afd020941bd23cbc0ca84dca4ecca58d",
      "relation": "hasVariant",
      "source": 41,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Results suggest O-GlcNAc modification at specifically Ser400 plays a critical role in hindering aggregation",
      "key": "5f0a66c2e2458b453f647616190ef9e8",
      "line": 487,
      "relation": "decreases",
      "source": 59,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Gazit, Segal and co-workers reported that their synthetic, O-GlcNAcylated PHF6 analogue, besides possessing reduced self-assembly propensity, seemed to inhibit unmodified PHF6 fibril formation upon co-incubation",
      "key": "4de9bc7b8c20a64cdc6466da8746a72f",
      "line": 577,
      "relation": "decreases",
      "source": 44,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Gazit, Segal and co-workers reported that their synthetic, O-GlcNAcylated PHF6 analogue, besides possessing reduced self-assembly propensity, seemed to inhibit unmodified PHF6 fibril formation upon co-incubation",
      "key": "22759638126dec0056bf275a6fc740f0",
      "line": 578,
      "relation": "decreases",
      "source": 44,
      "target": 8
    },
    {
      "key": "77249184e8b381b1399f101e03d6b28b",
      "relation": "hasVariant",
      "source": 43,
      "target": 44
    },
    {
      "key": "d27452e46263c87496a71903754fa081",
      "relation": "partOf",
      "source": 43,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "An inverse correlation between O-GlcNAcylation and AÎ² formation was reported",
      "key": "5e635862b3440e9014660a382a023df0",
      "line": 598,
      "relation": "negativeCorrelation",
      "source": 52,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent work indicated that O-GlcNAcylation of APP promotes its plasma membrane localization, facilitating its non-amyloidogenic processing",
      "key": "fb3227124b3c24abca2cd9ed3237fabd",
      "line": 626,
      "relation": "increases",
      "source": 52,
      "target": 52,
      "target_modifier": {
        "location": {
          "name": "plasma membrane",
          "namespace": "GO"
        }
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent work indicated that O-GlcNAcylation of APP promotes its plasma membrane localization, facilitating its non-amyloidogenic processing",
      "key": "b71cd66b1a7ac42ed0ca91e0b4de81ee",
      "line": 627,
      "relation": "increases",
      "source": 52,
      "source_modifier": {
        "location": {
          "name": "plasma membrane",
          "namespace": "GO"
        }
      },
      "target": 22
    },
    {
      "key": "525c8b236e70ed1aae6836ebee36320f",
      "relation": "hasVariant",
      "source": 50,
      "target": 52
    },
    {
      "key": "5efa9ea30f0b6cb4a55908d43e25d2ea",
      "relation": "hasVariant",
      "source": 50,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "An inverse correlation between O-GlcNAcylation and AÎ² formation was reported",
      "key": "107d210065b7b119f2e314ce3b7cbfcb",
      "line": 598,
      "relation": "negativeCorrelation",
      "source": 2,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "51f57f0614a164a5df4b4d6232841928",
      "line": 640,
      "relation": "association",
      "source": 2,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of the 5xFAD AÎ² mouse model with NButGT, another studied OGA inhibitor, impaired AÎ² production and attenuated activated gliosis",
      "key": "19df9cc7950e8ab6c233c496683e9338",
      "line": 607,
      "relation": "decreases",
      "source": 18,
      "target": 66,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of the 5xFAD AÎ² mouse model with NButGT, another studied OGA inhibitor, impaired AÎ² production and attenuated activated gliosis",
      "key": "f34bd95146b7f4e9d748b282cf2bc82b",
      "line": 608,
      "relation": "decreases",
      "source": 18,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of the 5xFAD AÎ² mouse model with NButGT, another studied OGA inhibitor, impaired AÎ² production and attenuated activated gliosis",
      "key": "adad29d4c50d049548fa8de5828179ad",
      "line": 609,
      "relation": "decreases",
      "source": 18,
      "target": 113
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Spinal Cord",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of even the mSOD mice with an OGA inhibitor, NButGT, increased levels of O-GlcNAc in the spinal cord.",
      "key": "a1660c086da75fe93b270967aa1c24ae",
      "line": 713,
      "relation": "increases",
      "source": 18,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "Medium",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "b6cdae1eb8504553ca64eb0bb354a0e2",
      "line": 640,
      "relation": "association",
      "source": 35,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Finally, treatment with prostaglandin J2 (PGJ2), an endogenous mediator of inflammation that promotes cleavage of secreted APP, is reported to increase overall levels of protein O-GlcNAcylation.",
      "key": "90231835842e3adb853ad9b25a2d51d8",
      "line": 650,
      "relation": "regulates",
      "source": 1,
      "target": 116
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Finally, treatment with prostaglandin J2 (PGJ2), an endogenous mediator of inflammation that promotes cleavage of secreted APP, is reported to increase overall levels of protein O-GlcNAcylation.",
      "key": "93fd3a9e7bd172fbcf253624158951ae",
      "line": 651,
      "relation": "increases",
      "source": 1,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Finally, treatment with prostaglandin J2 (PGJ2), an endogenous mediator of inflammation that promotes cleavage of secreted APP, is reported to increase overall levels of protein O-GlcNAcylation.",
      "key": "701728a1592ea5c532d90e7f4a768e54",
      "line": 652,
      "relation": "increases",
      "source": 1,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "d2f0f0d5d088d51be7613ced473d1150",
      "line": 661,
      "relation": "association",
      "source": 54,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "3d4e1ca9a9cc14a7392b9d6c550a2c44",
      "line": 662,
      "relation": "association",
      "source": 54,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "b1a7faa28e629006a070e79bdef24e0b",
      "line": 663,
      "relation": "decreases",
      "source": 54,
      "target": 24
    },
    {
      "key": "c627f2b299455f47c41ca06b001a929e",
      "relation": "hasVariant",
      "source": 54,
      "target": 55
    },
    {
      "key": "1da06ba5d4294aa57b904f12e4eef0d5",
      "relation": "hasVariant",
      "source": 54,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "317de15030d0d61b2a685ee301d16000",
      "line": 661,
      "relation": "association",
      "source": 33,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "6c35b7184b58c911c22cac0bc0b0bc5d",
      "line": 662,
      "relation": "association",
      "source": 53,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Instead, decreases in global O-GlcNAcylation levels is reported to be protective against huntingtin aggregation and cytotoxicity in neuroblastoma cells and fly models",
      "key": "1473fc8851b18ef79ac84e85fe7c3081",
      "line": 670,
      "relation": "increases",
      "source": 55,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Decreasing O-GlcNAcylation enhances autophagosomelysosome function, which leads to increased basal autophagy flux and clearance of toxic huntingtin aggregates",
      "key": "ca6f703e9df4538480b0c83f6869eea5",
      "line": 678,
      "relation": "decreases",
      "source": 55,
      "target": 13,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Decreasing O-GlcNAcylation enhances autophagosomelysosome function, which leads to increased basal autophagy flux and clearance of toxic huntingtin aggregates",
      "key": "aa4ec75e26277e51912e7afadadad605",
      "line": 676,
      "relation": "decreases",
      "source": 55,
      "target": 16,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Decreasing O-GlcNAcylation enhances autophagosomelysosome function, which leads to increased basal autophagy flux and clearance of toxic huntingtin aggregates",
      "key": "4f70096b4d2fdbbadc05ffaf7d153c96",
      "line": 677,
      "relation": "decreases",
      "source": 55,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Spinal Cord",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Mice carrying a mutation in superoxide dismutase 1 (SOD1) also exhibit decreased OGlcNAc levels in the spinal cord",
      "key": "fcc5ae44d0055624daaa8aac23aed440",
      "line": 695,
      "relation": "decreases",
      "source": 99,
      "target": 98
    },
    {
      "key": "40881f33876372803b644a8b66131745",
      "relation": "hasVariant",
      "source": 97,
      "target": 99
    },
    {
      "key": "0e01544a498674d8cc24f9513315c6c7",
      "relation": "hasVariant",
      "source": 97,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "first": "Ryan P",
        "identifier": "30985105",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "namespace": "pubmed",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Familial SOD1 mutations are responsible for 20% of familial ALS cases in humans",
      "key": "4cdc147eb0dabbce195e75891fd2be95",
      "line": 704,
      "relation": "increases",
      "source": 82,
      "target": 109
    },
    {
      "key": "1dd9720a67a0bafa7307ffc0f977ff98",
      "relation": "hasVariant",
      "source": 81,
      "target": 82
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 40\")",
      "concept": {
        "name": "amyloid-beta polypeptide 40",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9e0dfb730cc36c0afbaa05a340211fda"
    },
    {
      "bel": "a(CHEBI:\"prostaglandin J2\")",
      "concept": {
        "name": "prostaglandin J2",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "1ec0e20550eb3c2d2ac88e6b374d46f0"
    },
    {
      "bel": "a(CHEBI:amyloid-beta)",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "1bc8499994bfdd953f21795fb20a70bc"
    },
    {
      "bel": "a(CHEBI:glucose)",
      "concept": {
        "name": "glucose",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "8b4d8974cf8c0e5830f78bb44168cf4d"
    },
    {
      "bel": "a(CHEBI:phospholipid)",
      "concept": {
        "name": "phospholipid",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "7519dbbdb0e794eb7a0963f4f33cfd42"
    },
    {
      "bel": "a(CHEBI:sirolimus)",
      "concept": {
        "name": "sirolimus",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "561f7408129243e1ed091f506ef0dded"
    },
    {
      "bel": "a(CONSO:\"Dopaminergic cell groups\")",
      "concept": {
        "name": "Dopaminergic cell groups",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "c6887492303fe16ab5c5e5b763561300"
    },
    {
      "bel": "a(CONSO:\"Tau aggregates\")",
      "concept": {
        "name": "Tau aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "8e1da50e6008ffdd1b37825776666311"
    },
    {
      "bel": "a(CONSO:\"Tau fibrils\")",
      "concept": {
        "name": "Tau fibrils",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "1b18e2b527ac0db7353b67d4534c033e"
    },
    {
      "bel": "a(CONSO:\"Tau oligomers\")",
      "concept": {
        "name": "Tau oligomers",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "d45e1cc48bdfb58b4ead6900919dbbe3"
    },
    {
      "bel": "a(CONSO:\"alpha-synuclein aggregates\")",
      "concept": {
        "name": "alpha-synuclein aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "53fc23bd9119de24af4193a97807e463"
    },
    {
      "bel": "a(CONSO:\"alpha-synuclein fibrils\")",
      "concept": {
        "name": "alpha-synuclein fibrils",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "f5b5627dc21a2ebed276bedcb46eda96"
    },
    {
      "bel": "a(CONSO:\"alpha-synuclein oligomers\")",
      "concept": {
        "name": "alpha-synuclein oligomers",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "56edcb302ec17a7e26dafd6d02e279ad"
    },
    {
      "bel": "a(CONSO:\"huntingtin aggregates\")",
      "concept": {
        "name": "huntingtin aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "ddfb3dfcec37bcf8a1201a85c5723c38"
    },
    {
      "bel": "a(GO:\"neurofibrillary tangle\")",
      "concept": {
        "name": "neurofibrillary tangle",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "274b01539a0746fbee06884b2af6c533"
    },
    {
      "bel": "a(GO:\"synaptic vesicle\")",
      "concept": {
        "name": "synaptic vesicle",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "e01e57790c1fb1d6829181d1ed26fd86"
    },
    {
      "bel": "a(GO:autophagosome)",
      "concept": {
        "name": "autophagosome",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "ba5dcaa249a37bedb6b206d83ac47484"
    },
    {
      "bel": "a(GO:microtubule)",
      "concept": {
        "name": "microtubule",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "0fe6be9622e5650da7dca7cdced2f9db"
    },
    {
      "bel": "a(MESH:\"1,2-dideoxy-2'-propylglucopyranoso(2,1-d)-delta 2'-thiazoline\")",
      "concept": {
        "name": "1,2-dideoxy-2'-propylglucopyranoso(2,1-d)-delta 2'-thiazoline",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "aa78841fa286a20f0d700b12bc097bce"
    },
    {
      "bel": "a(MESH:Hexosaminidases)",
      "concept": {
        "name": "Hexosaminidases",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "2ac1a57052e739b1580c91790f2843f5"
    },
    {
      "bel": "a(PUBCHEM:135566354)",
      "concept": {
        "name": "135566354",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "b69ac4a46125f50c8cf6cefb257c5a29"
    },
    {
      "bel": "a(PUBCHEM:9576811)",
      "concept": {
        "name": "9576811",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "3c13f186cd3bf6b7a026183533649773"
    },
    {
      "bel": "bp(CONSO:\"APP processing\")",
      "concept": {
        "name": "APP processing",
        "namespace": "CONSO"
      },
      "function": "BiologicalProcess",
      "id": "d9c3ea10e4d58119f4b82eb7f80b3be2"
    },
    {
      "bel": "bp(GO:\"SNARE complex assembly\")",
      "concept": {
        "name": "SNARE complex assembly",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "05b30e5bec54e53322cb72ef79a7b35f"
    },
    {
      "bel": "bp(GO:\"apoptotic process\")",
      "concept": {
        "name": "apoptotic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9eb8739869ef0e82697f61a33d3d6afa"
    },
    {
      "bel": "bp(GO:\"brain development\")",
      "concept": {
        "name": "brain development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ac0c7c6bcd68b7fc8d43fa1e094e68f6"
    },
    {
      "bel": "bp(GO:\"cellular glucose homeostasis\")",
      "concept": {
        "name": "cellular glucose homeostasis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "38d143426a53e4cd93f3f403a1f1c9f0"
    },
    {
      "bel": "bp(GO:\"dopamine secretion\")",
      "concept": {
        "name": "dopamine secretion",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f8373ee025bfe1eb5b0d4ba08e51b739"
    },
    {
      "bel": "bp(GO:\"glucose metabolic process\")",
      "concept": {
        "name": "glucose metabolic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "57837c8bd480cd6e4257602591b12dac"
    },
    {
      "bel": "bp(GO:\"motor behavior\")",
      "concept": {
        "name": "motor behavior",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a2dcc4ec00ebc4321e0089baccd16aa5"
    },
    {
      "bel": "bp(GO:\"musculoskeletal movement\")",
      "concept": {
        "name": "musculoskeletal movement",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a5b6cb847910da20f24ca34c9e69796c"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "concept": {
        "name": "neuron death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5af039c1f3120f7215931236c3c03804"
    },
    {
      "bel": "bp(GO:\"protein phosphorylation\")",
      "concept": {
        "name": "protein phosphorylation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d87820d546d1a4519930b54d5a68d801"
    },
    {
      "bel": "bp(GO:\"vesicle transport along microtubule\")",
      "concept": {
        "name": "vesicle transport along microtubule",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "6939407599f79c53e5a5211c4947d7ec"
    },
    {
      "bel": "bp(GO:autophagy)",
      "concept": {
        "name": "autophagy",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9efc965fac6a195d0fad26eecddaac05"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "complex(a(CHEBI:phospholipid), p(HGNC:SNCA))",
      "function": "Complex",
      "id": "ec5500a7789b15340cb3ffc1025bf825",
      "members": [
        {
          "bel": "a(CHEBI:phospholipid)",
          "concept": {
            "name": "phospholipid",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "7519dbbdb0e794eb7a0963f4f33cfd42"
        },
        {
          "bel": "p(HGNC:SNCA)",
          "concept": {
            "name": "SNCA",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8cd39bc202ad944395c27f63d95f6908"
        }
      ]
    },
    {
      "bel": "complex(a(GO:microtubule), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "60e49c33ee1c6bbff236bae4989f16eb",
      "members": [
        {
          "bel": "a(GO:microtubule)",
          "concept": {
            "name": "microtubule",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "0fe6be9622e5650da7dca7cdced2f9db"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(CONSO:\"VQIVYK motif\"), p(CONSO:\"VQIVYK motif\"))",
      "function": "Complex",
      "id": "7d529cd123097dd1e5587a8d29b2c729",
      "members": [
        {
          "bel": "p(CONSO:\"VQIVYK motif\")",
          "concept": {
            "name": "VQIVYK motif",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "9b38965d99870547034625d1cd83bcfb"
        },
        {
          "bel": "p(CONSO:\"VQIVYK motif\")",
          "concept": {
            "name": "VQIVYK motif",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "9b38965d99870547034625d1cd83bcfb"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:SNCA), p(HGNC:SNCA))",
      "function": "Complex",
      "id": "c5827e439e158fd88cbc00efe1601ec9",
      "members": [
        {
          "bel": "p(HGNC:SNCA)",
          "concept": {
            "name": "SNCA",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8cd39bc202ad944395c27f63d95f6908"
        },
        {
          "bel": "p(HGNC:SNCA)",
          "concept": {
            "name": "SNCA",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8cd39bc202ad944395c27f63d95f6908"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:SNCA), p(HGNC:VAMP2))",
      "function": "Complex",
      "id": "faa0b82962e3687e75e76379e023d2b7",
      "members": [
        {
          "bel": "p(HGNC:SNCA)",
          "concept": {
            "name": "SNCA",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8cd39bc202ad944395c27f63d95f6908"
        },
        {
          "bel": "p(HGNC:VAMP2)",
          "concept": {
            "name": "VAMP2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "b4bb444c1610a72c1a48aa535f6320ac"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\")",
      "concept": {
        "name": "Tau isoform F (441 aa)",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "83682de7856cc379117e146862b26202"
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\", pmod(CONSO:O-GlcNAcylation))",
      "concept": {
        "name": "Tau isoform F (441 aa)",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "7e60164b716cd515b1efdc1338b0c8ca",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"VQIVYK motif\")",
      "concept": {
        "name": "VQIVYK motif",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "9b38965d99870547034625d1cd83bcfb"
    },
    {
      "bel": "p(CONSO:\"VQIVYK motif\", pmod(CONSO:O-GlcNAcylation))",
      "concept": {
        "name": "VQIVYK motif",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "f5fd6389ba7672bb8514c9c8c1985f08",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"alpha-synuclein fibrils\")",
      "concept": {
        "name": "alpha-synuclein fibrils",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "ac4d837bea56b4618a658554b8c62c01"
    },
    {
      "bel": "p(CONSO:\"alpha-synuclein fibrils\", frag(\"?\"))",
      "concept": {
        "name": "alpha-synuclein fibrils",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "6b5e31823c508c1a9a028caa99b0868f",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(CONSO:sAPP-alpha)",
      "concept": {
        "name": "sAPP-alpha",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "26e8e9b26633c7c3bf3b02e525ee9b53"
    },
    {
      "bel": "p(FPLX:AKT)",
      "concept": {
        "name": "AKT",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "e0ada1edbf208bbaa7cb0798a2462eb3"
    },
    {
      "bel": "p(FPLX:AKT, pmod(go:0006468 ! \"protein phosphorylation\"))",
      "concept": {
        "name": "AKT",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "d570dd06748b29867db2fefd2a5ec592",
      "variants": [
        {
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:APP)",
      "concept": {
        "name": "APP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d43ae551265c6b6a27038d0b036848cf"
    },
    {
      "bel": "p(HGNC:APP, frag(\"?\"))",
      "concept": {
        "name": "APP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1d7a8a2d778541f6083221fa6bb73dec",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:APP, pmod(CONSO:O-GlcNAcylation))",
      "concept": {
        "name": "APP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3e262f1045b3c4c13b47f917086d0271",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:BDNF)",
      "concept": {
        "name": "BDNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a638d5f84b9678f17c8795852300134a"
    },
    {
      "bel": "p(HGNC:HTT)",
      "concept": {
        "name": "HTT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b06bc161685303d07e7b94f740920bb7"
    },
    {
      "bel": "p(HGNC:HTT, pmod(CONSO:O-GlcNAcylation))",
      "concept": {
        "name": "HTT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a79c27b0a64164c3ce9d16e1906eda8e",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HTT, var(\"?\"))",
      "concept": {
        "name": "HTT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "dd761e916586afccb5d4da7eda423ad0",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:O-GlcNAcylation))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "74f55f226c74190102ea18d10ecd61a3",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:O-GlcNAcylation, Ser, 400))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1f073babd02eb4ea4a2a52120a831bd4",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 400
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:hyperphosphorylation))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0d2d8072f03dcdf148e658067d37b9cb",
      "variants": [
        {
          "concept": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(go:0006468 ! \"protein phosphorylation\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f12d372e20d49c261fa134ab17d23cdd",
      "variants": [
        {
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 396))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "05b87e8ec07e28b96d6ba7cdb66a5fa1",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 396
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(go:0006468 ! \"protein phosphorylation\", Thr, 231))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e02db2c7471dcbf8a2e953d4fe67eb64",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 231
        }
      ]
    },
    {
      "bel": "p(HGNC:MTOR)",
      "concept": {
        "name": "MTOR",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a2450afd51fecb876f80e78722f0ba96"
    },
    {
      "bel": "p(HGNC:MTOR, pmod(go:0006468 ! \"protein phosphorylation\"))",
      "concept": {
        "name": "MTOR",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3fe1c46753472bba6f153633badf09a1",
      "variants": [
        {
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:OGA)",
      "concept": {
        "name": "OGA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d4fa7628dcf93d39d434a1a4c6387ed9"
    },
    {
      "bel": "p(HGNC:OGT)",
      "concept": {
        "name": "OGT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "48d2a82c6bcb3e89526b69020087aa0d"
    },
    {
      "bel": "p(HGNC:SNCA)",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8cd39bc202ad944395c27f63d95f6908"
    },
    {
      "bel": "p(HGNC:SNCA, frag(\"68_77\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "512ba283710cf73fdbddd67007e1987c",
      "variants": [
        {
          "kind": "frag",
          "start": 68,
          "stop": 77
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, frag(\"68_77\"), pmod(CONSO:O-GlcNAcylation))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f00cc7d9e30d4a349fe82364df4be6c0",
      "variants": [
        {
          "kind": "frag",
          "start": 68,
          "stop": 77
        },
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, frag(\"?\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "54870156ad22d51dacf6de81ed27ef3a",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, frag(\"?_*\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cac98388ccfeaaf3cee012d0b5f46f35",
      "variants": [
        {
          "kind": "frag",
          "start": "?",
          "stop": "*"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:O-GlcNAcylation))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4f9546b170da332b49ce6aa86e4a97c1",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:O-GlcNAcylation, Ser, 87))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bfcde6ee8b26bb5f5c9c2f9e692c3129",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 87
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:O-GlcNAcylation, Ser, 87), pmod(CONSO:O-GlcNAcylation, Thr, 72), pmod(CONSO:O-GlcNAcylation, Thr, 81))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "28b436127706b1cc2b742f81ea518385",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 87
        },
        {
          "code": "Thr",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 72
        },
        {
          "code": "Thr",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 81
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:O-GlcNAcylation, Thr, 72))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "485fd96223d035a074643bc1c94bd290",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 72
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:O-GlcNAcylation, Thr, 75))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "742d8e2596ebd3bc923310cdb30d3f96",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 75
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:O-GlcNAcylation, Thr, 81))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cc676da80ec4addfc2cdac60e0d1f494",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 81
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(go:0006468 ! \"protein phosphorylation\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "20eb07e3bac827068ac6162e1781ffb7",
      "variants": [
        {
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"?\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "937de1ef5af195c85dd0c5e0fb175d14",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SOD1)",
      "concept": {
        "name": "SOD1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "706116ed914ade77428db2dcc85fff62"
    },
    {
      "bel": "p(HGNC:SOD1, var(\"?\"))",
      "concept": {
        "name": "SOD1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "29935d28463e4877708f3bfe4b35cf23",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:VAMP2)",
      "concept": {
        "name": "VAMP2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b4bb444c1610a72c1a48aa535f6320ac"
    },
    {
      "bel": "p(HGNCGENEFAMILY:Calpains)",
      "concept": {
        "name": "Calpains",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "7ca722526fc0d17a88d8dc58f35706a6"
    },
    {
      "bel": "p(MESH:Proteins)",
      "concept": {
        "name": "Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "5f95843f75d793290da323632314ec25"
    },
    {
      "bel": "p(MESH:Proteins, pmod(CONSO:O-GlcNAcylation))",
      "concept": {
        "name": "Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "13350c30aedf1b591b0679130e1586d1",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt)",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "a179f3829d42c3522d517c5ab2fc5b67"
    },
    {
      "bel": "p(MGI:Mapt, pmod(CONSO:O-GlcNAcylation))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "a8c71ac019d27906c3fb05a716fb54d4",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(CONSO:hyperphosphorylation))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "f949656a30c3fadb71b0c12f1af31027",
      "variants": [
        {
          "concept": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(go:0006468 ! \"protein phosphorylation\"))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "5db8c361c5fe40a2c53298abd854c5a0",
      "variants": [
        {
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 202), pmod(go:0006468 ! \"protein phosphorylation\", Ser, 205))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "86389f997f23ec010003133e3bf99d10",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 202
        },
        {
          "code": "Ser",
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 205
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 356))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "2afbc1a20281f564896b02de7828297d",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 356
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 396))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "ee9b84a8e0b763338e2c5c94ddab3418",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 396
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 400))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "667480fc92e4de339855d69003bba603",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 400
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 626))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "8c0fcf5f129060f1ad40ed4b764a2542",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 626
        }
      ]
    },
    {
      "bel": "p(MGI:Oga)",
      "concept": {
        "name": "Oga",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "9619f94595e73a908c1b5f5b8c36e3a0"
    },
    {
      "bel": "p(MGI:Sod1)",
      "concept": {
        "name": "Sod1",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "0ead17b7c5c4a222fe6f9167089950df"
    },
    {
      "bel": "p(MGI:Sod1, pmod(CONSO:O-GlcNAcylation))",
      "concept": {
        "name": "Sod1",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "e25100da5c4eafb39877a67305e0979c",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Sod1, var(\"?\"))",
      "concept": {
        "name": "Sod1",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "112b035b0b82fe8c692ce15838d22924",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt)",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "4491a7c731b98f8c5496132c49032c21"
    },
    {
      "bel": "p(RGD:Mapt, pmod(CONSO:O-GlcNAcylation))",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "e73ad02d614934b42501dd91d647cec0",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt, pmod(go:0006468 ! \"protein phosphorylation\"))",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "ce9bca77e72a12c53c87eea3bd5414e0",
      "variants": [
        {
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 396))",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "e5110b2a5592d63c73a2e7ae87d02307",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 396
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 422))",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "b7c7c9bfe0993181ff9ee2d9712f3a44",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 422
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt, pmod(go:0006468 ! \"protein phosphorylation\", Thr, 231))",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "ac888da4af6c3b9b08b5f65f957b96b8",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 231
        }
      ]
    },
    {
      "bel": "p(RGD:Oga)",
      "concept": {
        "name": "Oga",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "6f0a5908fed909c2a489bd4f0f1655cc"
    },
    {
      "bel": "path(HP:\"Postural instability\")",
      "concept": {
        "name": "Postural instability",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "455cae0056b268ce7ad9d7b4fe9cfce5"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "concept": {
        "name": "Alzheimer Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2ae8307f5fd59056199369691367cc96"
    },
    {
      "bel": "path(MESH:\"Amyotrophic Lateral Sclerosis\")",
      "concept": {
        "name": "Amyotrophic Lateral Sclerosis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "73a119af95b8953eff6c1a96ee76f056"
    },
    {
      "bel": "path(MESH:\"Muscle Rigidity\")",
      "concept": {
        "name": "Muscle Rigidity",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "6aef64b05afe13358b09ac1535703881"
    },
    {
      "bel": "path(MESH:\"Parkinson Disease\")",
      "concept": {
        "name": "Parkinson Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e45482025720b7db29c4fea458b4cae9"
    },
    {
      "bel": "path(MESH:\"Plaque, Amyloid\")",
      "concept": {
        "name": "Plaque, Amyloid",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ff45c3caeb411cd232d96d6ed01854d5"
    },
    {
      "bel": "path(MESH:Gliosis)",
      "concept": {
        "name": "Gliosis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "4662e4de5a80d3c9a0380007535e2195"
    },
    {
      "bel": "path(MESH:Hyperglycemia)",
      "concept": {
        "name": "Hyperglycemia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "434a44b2a5a2e5af4ba755a1b3825dec"
    },
    {
      "bel": "path(MESH:Hypokinesia)",
      "concept": {
        "name": "Hypokinesia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "205bfadff89a805493a4d7e958954c5f"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "concept": {
        "name": "Inflammation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10cd96fd4056a5e6c27264e0130e89f9"
    }
  ]
}